|
|
 |
|
Viewing report
|
|
|
|
BSD Medical Corporation (BSDM) - Product Pipeline Analysis
GlobalData, June 2011, Pages: 40
BSD Medical Corporation (BSDM) - Product Pipeline Analysis
Summary
BSD Medical Corporation (BSD) is engaged in the development, manufacture and marketing of treatment systems, which are used for the treatment of cancer and other diseases using heat therapy provided by focused radio frequency and microwave energy. Its product line for cancer therapy offers hospitals and clinics a complete solution for thermal treatment of cancer which is similar to the provision through microwave/RF systems. The product portfolio of the company includes MicroThermX-180, BSD-500, BSD-2000, BSD-2000/3D, and BSD-2000/3D/MR. BSD-500 is used to treat certain cancers located near the surface of the body. The BSD-2000 System is used to non-invasively treat certain deep cancers. MicroThermX MTX-180, has been developed to use precision-guided microwave energy to ablate soft tissue. BDS markets its products in the US through its independent sales representatives and it has appointed distributors in countries across Europe and Asia. BSD is headquartered in Utah, the US.
This report is a source for data, analysis and actionable intelligence on the BSD Medical Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
InSightec Ltd. - Product Pipeline Analysis
Hansen Medical, Inc. (HNSN) - Product Pipeline Analysis
MicroPort Scientific Corporation (853) - Product Pipeline Analysis
Medtronic, Inc. (MDT) - Product Pipeline Analysis
Cardima, Inc. (CADM) - Product Pipeline Analysis
Nanospectra Biosciences, Inc. - Product Pipeline Analysis
GUIDED THERAPEUTICS, INC. (GTHP) - Product Pipeline Analysis
Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis
Neogenix Oncology, Inc. - Product Pipeline Analysis
Biomoda, Inc. (BMOD) - Product Pipeline Analysis
|
|
|
|
